Sunrest Lifescience Limited (NSE:SUNREST)

India flag India · Delayed Price · Currency is INR
35.00
-1.00 (-2.78%)
May 25, 2026, 12:54 PM IST
Market Cap150.19M -43.6%
Revenue (ttm)520.34M +60.6%
Net Income17.60M
EPS4.10
Shares Out 4.29M
PE Ratio8.54
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume1,600
Open35.00
Previous Close36.00
Day's Range35.00 - 35.00
52-Week Range29.55 - 61.00
Beta0.24
Analystsn/a
Price Targetn/a
Earnings DateMay 29, 2026

About Sunrest Lifescience

Sunrest Lifescience Limited manufactures, sells, and markets healthcare products, medicines, and cosmetic products in India. It markets various drugs, including anti-bacterials, antibiotics, anti-amoeibics, anti- fungals, analgesic, neuropathy, anti-hypertension, anti-inflammatory, anti-ulcerants, anti-cold, anti-cough, anti-allergics, nutritionals, ayurvedic, and cosmetics in various forms, such as tablets, capsules, soft gels, syrup, dry-syrups, injections, cream-ointments, and powders. The company sells its products through a network of dist... [Read more]

Industry Medical - Pharmaceuticals
Sector Healthcare
Founded 2017
Employees 210
Stock Exchange National Stock Exchange of India
Ticker Symbol SUNREST
Full Company Profile

Financial Performance

In fiscal year 2025, Sunrest Lifescience's revenue was 334.13 million, an increase of 13.33% compared to the previous year's 294.83 million. Earnings were 20.05 million, an increase of 788.48%.

Financial Statements